Skip to content

Startup & venture capital news

Rivercell launches with USD 25m seed funding

HV Capital leads investment in AI models of human cell responses

By /

LinkedInX
Rivercell: Rivercell raises USD 25m seed round for cell research

Rivercell announced USD 25 million in seed funding on 7 October 2026, led by HV Capital. Yann Fleureau and Eric Durand founded the Paris company to combine experimental cell data with AI models that predict how human cells respond to treatment. The team is developing infrastructure for drug discovery, bringing laboratory information into computational models. Its work aims to help researchers study potential responses before committing to later development stages. The funding connects a research-focused technology approach with institutional capital. Rivercell's story sits within life sciences, where the purpose of the AI system is to support the development of medicines.

Keep reading

More Funding

All stories